Precise Mutagenesis in Zebrafish Using Cytosine Base Editors
Overview
Affiliations
Base editing is a powerful CRISPR-based technology for introducing precise substitutions into the genome. This technology greatly advances mutagenesis possibilities in vivo, particularly in zebrafish, for which the generation of precise point mutations is still challenging. Zebrafish have emerged as an important model for genetic studies and in vivo disease modeling. With the development of different base editor variants that recognize protospacer-adjacent motifs (PAMs) other than the classical 5'-NGG-3' PAM, it is now possible to design and test several guide RNAs to find the most efficient way to precisely introduce the desired substitution. Here, we describe the experimental design strategies and protocols for cytosine base editing in zebrafish, from guide RNA design and selection of base editor variants to generation of the zebrafish mutant line carrying the substitution of interest. By using co-selection by introducing a loss-of-function mutation in genes necessary for the formation of pigments, injected embryos with highly efficient base editing can be directly analyzed to determine the phenotypic impact of the targeted substitution. The generation of mutant embryos after base editor injections in zebrafish can be completed within 2 weeks.
ABE-ultramax for high-efficiency biallelic adenine base editing in zebrafish.
Qin W, Liang F, Lin S, Petree C, Huang K, Zhang Y Nat Commun. 2024; 15(1):5613.
PMID: 38965236 PMC: 11224239. DOI: 10.1038/s41467-024-49943-1.
Zebrafish Optokinetic Reflex: Minimal Reporting Guidelines and Recommendations.
Rodwell V, Patil M, Kuht H, Neuhauss S, Norton W, Thomas M Biology (Basel). 2024; 13(1).
PMID: 38275725 PMC: 10813647. DOI: 10.3390/biology13010004.
Exploring hematopoiesis in zebrafish using forward genetic screening.
Song H, Shin U, Nam U, Lee Y Exp Mol Med. 2024; 56(1):51-58.
PMID: 38172599 PMC: 10834449. DOI: 10.1038/s12276-023-01138-2.
Ravichandran M, Maddalo D Front Genet. 2023; 14:1273994.
PMID: 37908590 PMC: 10613999. DOI: 10.3389/fgene.2023.1273994.